Evidence map›Paper›PMID 35759349›Full record

ArticleSchizophrenia bulletin2022

Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia.

Vittal Korann, Arpitha Jacob, Bonian Lu, Priyanka Devi, Umesh Thonse, Bhargavi Nagendra, Dona Maria Chacko, Avyarthana Dey, Anantha Padmanabha, Venkataram Shivakumar and 6 more

Open access · bronzeAbstract readControlled Clinical Trial
In one paragraph

Article in Schizophrenia bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Imaging of intranasal drug delivery to the brain: updated review 2.0.Drug delivery and translational research · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Vittal KorannDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Arpitha JacobDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Bonian LuAU MRI Research Center, Department of Electrical and Computer Engineering, Auburn University, Auburn, AL, USA.
Priyanka DeviDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Umesh ThonseDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Bhargavi NagendraDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Dona Maria ChackoDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Avyarthana DeyDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Anantha PadmanabhaDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Venkataram ShivakumarDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Rose Dawn BharathDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Vijay KumarDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Shivarama VaramballyDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Ganesan VenkatasubramanianDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Gopikrishna DeshpandeAU MRI Research Center, Department of Electrical and Computer Engineering, Auburn University, Auburn, AL, USA.
Naren P RaoDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.ORCID 0000-0001-9272-1873
National Institute of Mental Health and Neurosciences · INAuburn University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEvidence from several lines of research suggests the critical role of neuropeptide oxytocin in social cognition and social behavior. Though a few studies have examined the effect of oxytocin on clinical symptoms of schizophrenia, the underlying neurobiological changes are underexamined. Hence, in this study, we examined the effect of oxytocin on the brain's effective connectivity in schizophrenia.

methods31 male patients with schizophrenia (SCZ) and 21 healthy male volunteers (HV) underwent resting functional magnetic resonance imaging scans with intra-nasal oxytocin (24 IU) and placebo administered in counterbalanced order. We conducted a whole-brain effective connectivity analysis using a multivariate vector autoregressive granger causality model. We performed a conjunction analysis to control for spurious changes and canonical correlation analysis between changes in connectivity and clinical and demographic variables.

resultsThree connections, sourced from the left caudate survived the FDR correction threshold with the conjunction analysis; connections to the left supplementary motor area, left precentral gyrus, and left frontal inferior triangular gyrus. At baseline, SCZ patients had significantly weaker connectivity from caudate to these three regions. Oxytocin, but not placebo, significantly increased the strength of connectivity in these connections. Better cognitive insight and lower negative symptoms were associated with a greater increase in connectivity with oxytocin.

conclusionsThese findings provide a preliminary mechanistic understanding of the effect of oxytocin on brain connectivity in schizophrenia. The study findings provide the rationale to examine the potential utility of oxytocin for social cognitive deficits in schizophrenia.

Indexed as

SchizophreniaAdministration, IntranasalBrainBrain MappingHumansMagnetic Resonance ImagingMaleOxytocinOxytocinfMRInegative symptomsneuropeptidepsychosissocial cognition

Identifiers

PMID35759349
PMCPMC9434443
OpenAlexW4283650970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.